Articles dans des revues avec comité de lecture (59)
  1. 37. Marteau, F., Le Poul, E., Communi, D., Communi, D., Labouret, C., Savi, P., Boeynaems, J.-M., & Suarez Gonzalez, N. (2003). Pharmacological characterization of the human P2Y13 receptor. Molecular Pharmacology, 64, 104-112. doi:10.1124/mol.64.1.104
  2. 38. Marteau, F., Le Poul, E., Communi, D., Communi, D., Labouret, C., Savi, P., Boeynaems, J.-M., & Suarez Gonzalez, N. (2003). Pharmacological Characterization of the Human P2Y13 Receptor. Molecular pharmacology, 64(1), 104-112. doi:10.1124/mol.64.1.104
  3. 39. Communi, D., Gevaert, K., Demol, H., Vandekerckhove, J., & Erneux, C. (2001). A novel receptor-mediated regulation mechanism of type I inositol polyphosphate 5-phosphatase by calcium/calmodulin-dependent protein kinase II phosphorylation. The Journal of biological chemistry, 276(42), 38738-38747. doi:10.1074/jbc.M105640200
  4. 40. Kotani, M., Detheux, M., Vandenbogaerde, A., Communi, D., Vanderwinden, J.-M., Le Poul, E., Brezillion, S., Tyldesley, R., Suarez Gonzalez, N., Vandeput, F., Blanpain, C., Schiffmann, S. N., Vassart, G., & Parmentier, M. (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. The Journal of biological chemistry, 276(37), 34631-34638. doi:10.1074/jbc.M104847200
  5. 41. Communi, D., Dewaste, V., & Erneux, C. (1999). Calcium-Calmodulin-dependent protein kinase II and protein kinase C-mediated phosphorylation and activation of D-myo-inositol 1,4,5-trisphosphate 3-kinase B in astrocytes. The Journal of biological chemistry, 274(21), 14734-14742. doi:10.1074/jbc.274.21.14734
  6. 42. Erneux, C., De Smedt, F., & Communi, D. (1998). The control mechanisms of inositol 1,4,5-trisphosphate by its own metabolism. Cell Biology International, 22(5), 372. doi:10.1006/cbir.1998.0254
  7. 43. Erneux, C., Govaerts, C., Communi, D., & Pesesse, X. (1998). The diversity and possible functions of the inositol polyphosphate 5-phosphatases. B B A - Molecular and Cell Biology of Lipids, 1436(1-2), 185-199. doi:10.1016/S0005-2760(98)00132-5
  8. 44. Communi, D., Vanweyenberg, V., & Erneux, C. (1997). D-myo-inositol 1,4,5-trisphosphate 3-kinase A is activated by receptor activation through a calcium:calmodulin-dependent protein kinase II mechanism. The E M B O Journal, 16(8), 1943-1952. doi:10.1093/emboj/16.8.1943
  9. 45. Communi, D., & Erneux, C. (1997). Identification of Three Active Site Residues Involved in Substrate Binding by Human 43 kDa-D-myo-Inositol, 1,4,5-Trisphosphate 5-Phosphatase. NATO ASI series. Series H. Cell biology, 102, 97-100. doi:10.1007/978-3-642-60848-3_16
  10. 46. Communi, D., Pirotton, S., Parmentier, M., & Boeynaems, J.-M. (1996). Cloning of human pyrimidinergic receptors. Drug development research, 37(3), 111. doi:10.1002/(SICI)1098-2299(199603)37:3<109::AID-DDR1>3.0.CO;2-Q
  11. 47. Communi, D., Lecocq, R., & Erneux, C. (1996). Arginine 343 and 350 are two active site residues involved in substrate binding by human type I D-myo-Inositol 1,4,5-Trisphosphate 5-Phosphatase. The Journal of biological chemistry, 271(20), 11676-11683. doi:10.1074/jbc.271.20.11676
  12. 48. Drayer, A. L., Pesesse, X., De Smedt, F., Communi, D., Moreau, C., & Erneux, C. (1996). The family of inositol and phosphatidylinositol polyphosphate 5-phosphatases. Biochemical Society Transactions, 24(4), 1001-1005.
    13. << Précédent 1 2 3 4 5 6 Suivant >>